Tackling the threat of antimicrobial resistance: from policy to sustainable action

@article{Shallcross2015TacklingTT,
  title={Tackling the threat of antimicrobial resistance: from policy to sustainable action},
  author={L. Shallcross and S. Howard and Tom A Fowler and S. Davies},
  journal={Philosophical Transactions of the Royal Society B: Biological Sciences},
  year={2015},
  volume={370}
}
Antibiotics underpin all of modern medicine, from routine major surgery through to caesarean sections and modern cancer therapies. These drugs have revolutionized how we practice medicine, but we are in a constant evolutionary battle to evade microbial resistance and this has become a major global public health problem. We have overused and misused these essential medicines both in the human and animal health sectors and this threatens the effectiveness of antimicrobials for future generations… Expand
Non-antibiotic pharmaceutical agents as antibiotic adjuvants
TLDR
The issue of antibiotic resistance in the 21st century is a three-sided problem: i) the emerge of drugresistant mutants against newly developed antibiotics is an inevitable evolutionary process, while the non-prudent use of antibiotics only exacerbates this process; ii) the costs of clinical research and the development of novel antibiotics – coupled with the relatively modest returns on investment from these drugs – lead to a shift in the interest of pharmaceutical companies to instead develop drugs for chronic illnesses. Expand
Antimicrobial Stewardship: Fighting Antimicrobial Resistance and Protecting Global Public Health
TLDR
This review highlights AMR’s scale and consequences, the importance, and implications of an antimicrobial stewardship program (ASP) to fight resistance and protect global health. Expand
Measuring and mapping the global burden of antimicrobial resistance
TLDR
The inclusion of mortality and morbidity data related to drug-resistant infections into the annual Global Burden of Disease Study should help fill the evidence base to drive forward research and policy agendas to combat AMR. Expand
Much more is expected from nations to counter antimicrobial resistance: World Health Organization
TLDR
It is very important to understand that antibiotic resistance has spread to the entire world, and is jeopardizing the act of treating common infections in both community and healthcare establishment settings. Expand
Future antibacterial strategies: from basic concepts to clinical challenges.
TLDR
Ongoing investigations extend large scale microbiome analyses to new natural sources, target the host-pathogen interface, include nanotechnologies and rejuvenate old paths, such as phages and bacteriocins, which should help to improve future prevention and treatment of MDR bacterial infections. Expand
The evolving response to antibiotic resistance (1945–2018)
The intensity and character of concerns about antibiotic resistance, over the past nearly seventy-five years, have depended on a series of linked factors: the evolution and distribution of resistantExpand
The Concept of an Ideal Antibiotic: Implications for Drug Design
TLDR
The aim of this review is to summarize current advances regarding the challenges of antibiotic drug discovery and the specific attributes of an ideal antibacterial drug. Expand
Antibiotics in the clinical pipeline at the end of 2015
There is growing global recognition that the continued emergence of multidrug-resistant bacteria poses a serious threat to human health. Action plans released by the World Health Organization andExpand
How promising are combinatorial drug strategies in combating Candida albicans biofilms?
TLDR
In this Editorial, it is proposed that, in addition to screening for novel antibiofilm or antipersister compounds, combination therapy might be a valid alternative to existing antimicrobial therapy. Expand
Strategies to Improve Antimicrobial Utilization with a Special Focus on Developing Countries
TLDR
A narrative review of ongoing activities across sectors was undertaken to improve antimicrobial use and address issues with vaccines including COVID-19 and it is imperative to develop new quality indicators for ambulatory care given current concerns. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 24 REFERENCES
A new antibiotic kills pathogens without detectable resistance
TLDR
The properties of this compound suggest a path towards developing antibiotics that are likely to avoid development of resistance, as well as several methods to grow uncultured organisms by cultivation in situ or by using specific growth factors. Expand
Assessing the impact of national antibiotic campaigns in Europe
TLDR
Evidence is found that public campaigns significantly reduce the use of antimicrobials in the community by 1.3–5.6 defined daily doses per 1,000 inhabitants yearly, which represents an impact of roughly 6.5–28.3 % on the mean level of antibiotic use in Europe between 1997 and 2007. Expand
Antibiotic resistance threats in the United States: stepping back from the brink.
TLDR
The physician's role in this effort to prevent and controlling resistance is singularly important and requires the engagement of many different sectors of society. Expand
Tracking a Hospital Outbreak of Carbapenem-Resistant Klebsiella pneumoniae with Whole-Genome Sequencing
TLDR
Tracking a hospital outbreak of carbapenem-resistant Klebsiella pneumoniae with whole-genome sequencing revealed its origin and probable modes of transmission, and revealed the weaknesses in this medical who-done-it, informing improvements in hospital preventive measures. Expand
Characteristics and outcomes of public campaigns aimed at improving the use of antibiotics in outpatients in high-income countries.
TLDR
Although the most effective interventions and potential adverse outcomes remain unclear, public campaigns can probably contribute to more careful use of antibiotics in outpatients, at least in high-prescribing countries. Expand
Challenges of Antibacterial Discovery
  • L. Silver
  • Biology, Medicine
  • Clinical Microbiology Reviews
  • 2011
TLDR
The purpose of this review is to underscore and illustrate those scientific problems unique to the discovery and optimization of novel antibacterial agents that have adversely affected the output of the effort. Expand
The European Antibiotic Awareness Day.
TLDR
The European Antibiotic Awareness Day will be an annually recurring event that will raise awareness about the risks associated with inappropriate use of antibiotics and how to use antibiotics responsibly. Expand
Mandatory surveillance of methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia in England: the first 10 years.
TLDR
The enhanced mandatory surveillance scheme in England has captured a wealth of data that have helped to further define the epidemiology of MRSA bacteraemia and it is to be hoped that based on the English experience of mandatory surveillance, other countries will consider the implementation of similar schemes. Expand
Annual Report of the Chief Medical Officer. 2011 Infections and the rise of antimicrobial resistance 2011. https://www.gov.uk/government/uploads/ system/uploads/attachment_data/file
  • Annual Report of the Chief Medical Officer. 2011 Infections and the rise of antimicrobial resistance 2011. https://www.gov.uk/government/uploads/ system/uploads/attachment_data/file
  • 2015
Department of Health. UK 5 year antimicrobial resistance strategy 2013 to 2018. https://www.gov. uk/government/uploads/system/uploads/ attachment_data/file
  • Department of Health. UK 5 year antimicrobial resistance strategy 2013 to 2018. https://www.gov. uk/government/uploads/system/uploads/ attachment_data/file
  • 2015
...
1
2
3
...